Skip to content

Smartphone Application for Initiation of Protective Ventilation. Clinical Impact of Instrumental Dead Space Reduction

Development and Evaluation of Smartphone App for Initiation of Protective Ventilation. Clinical Impact of Instrumental Dead Space Reduction on Physiologic Parameter Based on the Smartphone App

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04390360
Acronym
Ventilo
Enrollment
20
Registered
2020-05-15
Start date
2019-11-01
Completion date
2024-06-30
Last updated
2023-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, Human, Humidifier Lung, Mechanical Ventilation Complication

Brief summary

Clinical evaluation of a new educative tools (Smartphone application) based on impact of instrumental dead space reduction after initiation of protective ventilation during mechanical ventilation.

Interventions

PROCEDUREProtective ventilation implementation

In this condition, we will implement the protective ventilation related with gender and height . A blood gas will be performed at before protective ventilation implementation and at the end of this condition.Time condition 30 minutes

PROCEDUREProtective ventilation with HME

In this condition, the patient will received protective ventilation with a Heat Moisture Exchanger (HME). A blood gas will be performed at the end of this condition.Time condition 30 minutes

PROCEDUREProtective ventilation with Heated humidifier

In this condition, the patient will received protective ventilation with a Heated humidifier. A blood gas will be performed at the end of this condition.Time condition 30 minutes

PROCEDURETidal Volume reduction

n this condition, we will reduce Tidal volume (with smartphone application calculation) to obtain the same alveolar ventilation (PaCO2) obtained on the HME condition

Sponsors

Laval University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years old * Mechanical ventilation (control,assist control or SIMV mode) * haemodynamic stability (vasopressor \< 0.2 ug/kg/min) * no prone position schedule in the next 2 hours following procedure inclusion * presence of an Arterial catheter

Exclusion criteria

* ECMO or anticipate ECMO * body temperature \< 36.0 for post operative patient (cardiac surgery)

Design outcomes

Primary

MeasureTime frameDescription
PaCO2 Variation60 minutes post interventionThe primary outcome is to evaluate the PaCO2 variation at the end of condition 2 (after 30 minutes with protective ventilation+ HME) and condition 4 (30 minutes after Tidal volume reduction + Heater humidifier). Variation \<= 10% of PaCO2

Secondary

MeasureTime frameDescription
Correlation between PCO2 variation and alveolar ventilation variation60 and 90 minutes post interventionWe will compare PaCO2 level variation and the alveolar ventilation variation to establish correlation. Correlation variation under 10% will be significative
Hemodynamic impact vs pHBaseline, 30, 60, 90 and 120 minutes post interventionCardiac echographic measurement (LeftVentricularEjectionFraction) in relation with acidosis status

Countries

Canada

Contacts

Primary ContactFrançois Lellouche
Francois.Lellouche@criucpq.ulaval.ca1-418-656-8711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026